The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

1. In order to explore potential therapeutic implications of cannabinoid antagonists, the effects of the prototypical cannabinoid antagonist SR141716A on monoamine efflux from the medial prefrontal cortex and the nucleus accumbens of the rat were investigated by in vivo microdialysis. 2. SR141716A m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tzavara, Eleni T, Davis, Richard J, Perry, Kenneth W, Li, Xia, Salhoff, Craig, Bymaster, Frank P, Witkin, Jeffrey M, Nomikos, George G
Formato: Artigo
Idioma:Inglês
Publicado em: 2003
Assuntos:
Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1573706/
https://ncbi.nlm.nih.gov/pubmed/12598408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0705100
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados